此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

先兆子痫后使用阿司匹林治疗:TAP 试验 (TAP)

2026年9月17日 更新者:Malamo Countouris

The objective of this research project is to conduct a single-site pilot trial to assess the feasibility and effect of low-dose aspirin to augment vascular recovery in the immediate postpartum period after preeclampsia through two specific aims: 1) to pilot test the feasibility of conducting a randomized controlled trial of postpartum low dose aspirin vs. placebo, and 2) to assess the effect of postpartum aspirin on endothelial function and blood pressure. Our central hypothesis is that postpartum administration of low-dose aspirin following preeclampsia will be feasible, improve endothelial function, and lower BP at 6 months postpartum. Subjects will undergo 3 study visits involving BP measurements, blood draws, questionnaires, and/or microiontophoresis. Up to 60 adult subjects will be enrolled at Magee-Women's Hospital.

研究概览

详细说明

This is a pilot randomized, single-center, double-blind placebo-control study of low dose aspirin in postpartum individuals with preeclampsia. Individuals will be randomized at the time of delivery 1:1 to 81mg of low-dose aspirin or identical appearing placebo daily for six months postpartum. Treatment and control groups will monitor home blood pressure throughout the study period and undergo two study visits. At each study visit, participants will undergo a blood draw, blood pressure measurement and assessment of endothelial function with microiontophoresis. Participant adherence will be monitored through pill counts, text message check-ins, patient diary and biochemical monitoring.

研究类型

介入性

注册 (估计的)

60

阶段

  • 第四阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

  • 姓名:Alisse K Hauspurg, MD
  • 电话号码:412-641-1381
  • 邮箱:janickia@upmc.edu

研究联系人备份

  • 姓名:Sila Yavan, MS
  • 电话号码:4124174981
  • 邮箱:yavans@upmc.edu

学习地点

    • Pennsylvania
      • Pittsburgh、Pennsylvania、美国、15213
        • 招聘中
        • University of Pittsburgh Magee-Womens Hospital
        • 接触:
        • 首席研究员:
          • Alisse K Hauspurg, MD

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 55年 (成人)

接受健康志愿者

不

有资格学习的性别

女性

描述

Inclusion Criteria:

  • Postpartum individuals ≥18 years old
  • Preeclampsia diagnosis

Exclusion Criteria:

  • Fetal anomaly
  • Multiple gestation
  • Pre-pregnancy hypertension
  • Allergy or contraindication to low-dose aspirin
  • Pre-pregnancy diabetes

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:其他
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:三倍

武器和干预

参与者组/臂
干预/治疗
安慰剂比较:Placebo Group

Similar appearing placebo pill daily for 6 months will be given to subjects.

The control group will receive similar appearing placebo daily for 6 months.

实验性的:Intervention Group

Low-dose [81 mg] aspirin pill daily for 6 months will be given to subjects

The intervention group will receive low-dose [81 mg] aspirin pill daily for 6 months.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Percent of participants eligible, enrolled and retained (feasibility)
大体时间:Baseline to approximately 6 months postpartum

To determine the feasibility of conducting a single-site randomized controlled trial of 6 months of postpartum low-dose aspirin vs. placebo in women with preeclampsia.

Baseline to approximately 6 months postpartum

次要结果测量

结果测量
措施说明
大体时间
Study visit systolic BP
大体时间:2 months postpartum

Mean study visit systolic BP

2 months postpartum
Study visit diastolic BP
大体时间:2 months postpartum

Mean study visit diastolic BP

2 months postpartum
Study visit systolic BP
大体时间:6 months postpartum

Mean study visit systolic BP

6 months postpartum
Study visit diastolic BP
大体时间:6 months postpartum

Mean study visit diastolic BP

6 months postpartum
Study visit mean arterial pressure
大体时间:2 months postpartum

Mean study visit mean arterial pressure ((2*diastolic BP + systolic BP / 3))

2 months postpartum
Study visit mean arterial pressure
大体时间:6 months postpartum

Mean study visit mean arterial pressure ((2*diastolic BP + systolic BP / 3))

6 months postpartum
Anti-hypertensive medication use
大体时间:2 months postpartum

Use of anti-hypertensive medication (percent of participants)

2 months postpartum
Anti-hypertensive medication use
大体时间:6 months postpartum

Use of anti-hypertensive medication (percent of participants)

6 months postpartum
Therapeutic intensity score
大体时间:2 months postpartum

Therapeutic intensity score for those on anti-hypertensive medications. Range of scores 0 to 5 (higher number indicates higher doses and number of anti-hypertensive medications; worse outcome)

2 months postpartum
Therapeutic intensity score
大体时间:6 months postpartum

Therapeutic intensity score for those on anti-hypertensive medications. Range of scores 0 to 5 (higher number indicates higher doses and number of anti-hypertensive medications; worse outcome)

6 months postpartum
Mean home systolic blood pressure
大体时间:delivery through 6 months postpartum

Mean home systolic blood pressure

delivery through 6 months postpartum
Mean home diastolic blood pressure
大体时间:delivery through 6 months postpartum

Mean home diastolic blood pressure

delivery through 6 months postpartum
Mean home mean arterial pressure
大体时间:delivery through 6 months postpartum

Mean home mean arterial pressure

delivery through 6 months postpartum
Mean daytime systolic blood pressure
大体时间:6 months postpartum

Mean daytime systolic blood pressure on ambulatory blood pressure monitoring

6 months postpartum
Mean nocturnal systolic blood pressure
大体时间:6 months postpartum

Mean nocturnal systolic blood pressure on ambulatory blood pressure monitoring

6 months postpartum
Mean daytime diastolic blood pressure
大体时间:6 months postpartum

Mean daytime diastolic blood pressure on ambulatory blood pressure monitoring

6 months postpartum
Mean nocturnal diastolic blood pressure
大体时间:6 months postpartum

Mean nocturnal diastolic blood pressure on ambulatory blood pressure monitoring

6 months postpartum
Mean nocturnal mean arterial pressure
大体时间:6 months postpartum

Mean nocturnal mean arterial pressure on ambulatory blood pressure monitoring

6 months postpartum
Mean daytime mean arterial pressure
大体时间:6 months postpartum

Mean daytime mean arterial pressure on ambulatory blood pressure monitoring

6 months postpartum
Mean overall mean arterial pressure
大体时间:6 months postpartum

Mean overall mean arterial pressure on ambulatory blood pressure monitoring

6 months postpartum
Mean overall systolic blood pressure
大体时间:6 months postpartum

Mean overall systolic blood pressure on ambulatory blood pressure monitoring

6 months postpartum
Mean overall diastolic blood pressure
大体时间:6 months postpartum

Mean overall diastolic blood pressure on ambulatory blood pressure monitoring

6 months postpartum
Classification of hypertension
大体时间:2 months postpartum

Stage 1, stage 2 hypertension (percent of participants with each stage)

2 months postpartum
Classification of hypertension
大体时间:6 months postpartum

Stage 1, stage 2 hypertension (percent of participants with each stage)

6 months postpartum
Endothelial function EC50%
大体时间:2 months postpartum

EC50% from microiontophoresis

2 months postpartum
Endothelial function EC50%
大体时间:6 months postpartum

EC50% from microiontophoresis

6 months postpartum
Endothelial function Emax
大体时间:2 months postpartum

Emax from microiontophoresis

2 months postpartum
Endothelial function Emax
大体时间:6 months postpartum

Emax from microiontophoresis

6 months postpartum
Endothelial function change in Emax
大体时间:2 to 6 months postpartum

Change in Emax between visits

2 to 6 months postpartum
Endothelial function change in EC50%
大体时间:2 to 6 months postpartum

Change in EC50% between visits

2 to 6 months postpartum
Change in systolic blood pressure
大体时间:2 to 6 months postpartum

Change in study visit mean systolic blood pressure between visits

2 to 6 months postpartum
Change in diastolic blood pressure
大体时间:2 to 6 months postpartum

Change in study visit mean diastolic blood pressure between visits

2 to 6 months postpartum
Change in mean arterial pressure
大体时间:2 to 6 months postpartum

Change in study visit mean arterial pressure between visits

2 to 6 months postpartum

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Alisse K Hauspurg, MD、UPMC Magee Women's Hospital

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2024年5月29日

初级完成 (估计的)

2027年1月1日

研究完成 (估计的)

2027年10月1日

研究注册日期

首次提交

2024年2月15日

首先提交符合 QC 标准的

2024年2月19日

首次发布 (实际的)

2024年2月28日

研究记录更新

最后更新发布 (实际的)

2026年9月22日

上次提交的符合 QC 标准的更新

2026年9月17日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

Deidentified data (including data dictionaries) will be shared at the discretion of the primary investigator. Data will include blood pressure, weight, demographics, physical activity, and pregnancy related information. Additional documents (such as the study protocol) will be made available.

IPD 共享时间框架

Within a year after outcomes are published and no later than 3 years after the end of clinical activities.

IPD 共享访问标准

NHLBI data repository request process

IPD 共享支持信息类型

  • 研究方案

药物和器械信息、研究文件

研究美国 FDA 监管的药品

是的

研究美国 FDA 监管的设备产品

不

在美国制造并从美国出口的产品

是的

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅